Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 4
1985 1
1986 5
1987 2
1990 1
1991 1
1993 1
2000 1
2001 1
2004 2
2005 3
2007 2
2008 3
2009 4
2010 3
2011 7
2012 4
2013 5
2014 2
2015 2
2017 2
2018 1
2019 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Sukul D, Seth M, Schreiber T, Hanzel G, Khandelwal A, Cannon LA, Lalonde TA, Gurm HS. Sukul D, et al. Among authors: cannon la. J Interv Cardiol. 2017 Aug;30(4):291-300. doi: 10.1111/joic.12388. Epub 2017 May 22. J Interv Cardiol. 2017. PMID: 28543770 Free PMC article.
The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
Sukul D, Seth M, Schreiber T, Khandelwal A, Cannon LA, LaLonde TA, Gurm HS. Sukul D, et al. Among authors: cannon la. Catheter Cardiovasc Interv. 2017 Nov 1;90(5):724-732. doi: 10.1002/ccd.27001. Epub 2017 Mar 17. Catheter Cardiovasc Interv. 2017. PMID: 28303632 Free PMC article.
Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results.
Kereiakes DJ, Cannon LA, Dauber I, Ball M, Bertolet B, Foster M, Nersesov AY, Underwood PL, Allocco DJ, Dawkins KD. Kereiakes DJ, et al. Among authors: cannon la. Catheter Cardiovasc Interv. 2015 Nov 15;86(6):994-1001. doi: 10.1002/ccd.25877. Epub 2015 Feb 25. Catheter Cardiovasc Interv. 2015. PMID: 25678402 Clinical Trial.
Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions.
Teirstein PS, Meredith IT, Feldman RL, Rabinowitz AC, Cannon LA, Lee TC, Dens J, Dubois CL, Mooney MR, Pompili VJ, Saito S, Allocco DJ, Dawkins KD, Stone GW. Teirstein PS, et al. Among authors: cannon la. Catheter Cardiovasc Interv. 2015 Feb 1;85(2):207-15. doi: 10.1002/ccd.25565. Epub 2014 Jul 4. Catheter Cardiovasc Interv. 2015. PMID: 24905795 Clinical Trial.
Stenting and medical therapy for atherosclerotic renal-artery stenosis.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators. Cooper CJ, et al. N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18. N Engl J Med. 2014. PMID: 24245566 Free PMC article. Clinical Trial.
57 results